Here, we did not observe any differences in CD200 expression on CD8 + T cells; furthermore, we previously reported that dual blockade of CD200 and PD-1 further reduces tumor burden in a subcutaneous pancreatic tumor model [33]. The gene discussed is CD8A; the disease is pancreatic neoplasm.